It has been reported that the inhibition of Nrf2 can sensitize some lung carcinoma cells to chemotherapeutic drugs under normoxic culture conditions [23], but the role of Nrf2 in hypoxia-induced chemotherapeutic resistance in tumors is not well understood. Here, NFE2L2 is linked to lung carcinoma.